contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


dagens-aktienyheder-0302-2026-iss-og-embla

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Equity Research Assistant

Victor Skriver

ISS is a service company that offers services in cleaning, security, and catering. Examples of services include maintenance and supervision, floor care and window cleaning, plant decoration, and telephony services. Customers are found in most industries and on a global level, with the largest operations in the Nordic market. The company was founded in 1901 and is headquartered in Søborg, Denmark. 

Embla Medical is a leading global provider of innovative mobility solutions in the medical technology space. Embla Medical improves people’s mobility through the delivery of Prosthetics, Bracing & Supports, and accompanying patient care. Headquartered in Iceland, the company employs over 4,000 people located across 36 countries worldwide. Embla Medical has extensive operations in the Americas, Europe, and Asia, as well as distributors in other markets.  

Embla Medical

Dagens aktienyheder 03/02-2026: ISS og Embla

ISS meddeler her til morgen at selskabet har indg&#xe5;et en ny stor IFS-kontrakt med en ny UK-baseret kunde til en v&#xe6;rdi p&#xe5; mere end DKK 100 mio. &#xe5;rligt. Aftalen ventes at starte op i Q4 2026, og l&#xf8;ber 5 &#xe5;r frem. Det er den anden meddelelse fra ISS i &#xe5;r efter selskabet i sidste uge annoncerede en udvidelse af en eksisterende kontrakt med en kunde i Schweiz. I 2025 udsendte ISS omkring 25 af disse kontrakts meddelelser.
Embla har her til morgen aflagt &#xe5;rsregnskab for 2025. Ser vi p&#xe5; fjerde kvartal, landede oms&#xe6;tningen p&#xe5; USD 257 mio., i tr&#xe5;d med analytikernes forventninger, svarende til en organisk v&#xe6;kst p&#xe5; 7% og 10% i lokal valuta inklusive opk&#xf8;b. V&#xe6;ksten var - som gennem &#xe5;ret - prim&#xe6;rt drevet af Prosthetics &amp; Neuro Orthotics, mens Bracing &amp; Supports var flad, og Patient Care leverede 5% organisk v&#xe6;kst. Sidstn&#xe6;vnte er et mindre positivt signal efter svag udvikling i divisionen gennem st&#xf8;rstedelen af 2025. EBITDA landede p&#xe5; USD 48 mio., svarende til en EBITDA-margin p&#xe5; 19%, hvilket var under forventningerne, mens bundlinjen landede som ventet. Den lavere margin skyldtes prim&#xe6;rt en lavere bruttomargin end ventet, negativ valutap&#xe5;virkning samt effekter fra told og fortsatte initiativer i Patient Care. P&#xe5; &#xe5;rsbasis endte EBITDA-marginen p&#xe5; 20%, p&#xe5; niveau med 2024. For 2026 guider Embla med en organisk oms&#xe6;tningsv&#xe6;kst p&#xe5; 5-8% samt en EBITDA-margin p&#xe5; 20-22%, drevet af volumenv&#xe6;kst i kerneforretningen, moderate prisstigninger og fortsatte skala- og effektiviseringsgevinster. Det relativt brede margininterval afspejler fortsat usikkerhed relateret til effekter fra amerikansk told. Samlet set ligger guidance inden for rammerne af selskabets langsigtede m&#xe5;ls&#xe6;tninger om 5-7% organisk v&#xe6;kst og en gradvis forbedring af EBITDA-marginen over tid. Vi afholder senere i dag et event med ledelsen, hvor fokus forventes at v&#xe6;re rettet mod den relativt brede EBITDA-margin guidance for 2026, den svagere marginudvikling i afslutningen af 2025 samt de faktorer, der vil afg&#xf8;re, om selskabet lander i den lave eller h&#xf8;je ende af guidance-intervallet i 2026. tilmeld dig her:&#xa0;<a href="https://www.inderes.dk/videos/embla-medical-presentation-of-the-annual-report-2025">https://www.inderes.dk/videos/embla-medical-presentation-of-the-annual-report-2025</a>
Disclaimer: HC Andersen Capital modtager betaling fra det n&#xe6;vnte selskab for en digital IR abonnementsaftale. /Victor Skriver d. 03/02/2026 kl. 08:50.

Stay up to date